Equillium, Inc. (EQ) Financials

EQ Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 63.1 million 3.6 million
Dec. 31, 2025 31.9 million 3.3 million
Sept. 30, 2025 34.5 million 3.6 million
June 30, 2025 12.4 million 7.3 million

EQ Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -4.3 million 930000
Dec. 31, 2025 -3.2 million 737000
Sept. 30, 2025 -8.4 million 401000
June 30, 2025 -3.0 million 563000

EQ Net Income

No data available :(

EQ Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 61.3 million 251000 692000
Dec. 31, 2025 30.3 million 356000 719000
Sept. 30, 2025 33.1 million 473000 745000
June 30, 2025 11.5 million - 259000

EQ Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 96.3 million
Dec. 31, 2025 91.9 million
Sept. 30, 2025 35.7 million
June 30, 2025 35.7 million

EQ Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 3000 3.0 million 2.6 million -
Dec. 31, 2025 44000 1.5 million 2.4 million -
Sept. 30, 2025 - 1.3 million 3.3 million -
June 30, 2025 - 4.1 million 2.1 million -

EQ Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 24000
Dec. 31, 2025 - 23000
Sept. 30, 2025 - 28000
June 30, 2025 - 32000

EQ Revenue by Segment
Graph available only for paid members. Upgrade to see it.

EQ

Price: $2.82

52 week price:
0.27
3.45

Earnings Per Share: -0.21 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 25774

Market Capitalization: 104.4 million

Links: